CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹78 Cr | ₹50 Cr | ₹211 Cr | ₹173 Cr | ₹74 Cr |
What is the latest Capital Work in Progress ratio of CONCORD BIOTECH ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹78 Cr |
| Mar2025 | ₹50 Cr |
| Mar2024 | ₹211 Cr |
| Mar2023 | ₹173 Cr |
| Mar2022 | ₹74 Cr |
How is Capital Work in Progress of CONCORD BIOTECH Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹78 Cr | 55.91 | |
| Mar2025 | ₹50 Cr | -76.30 | |
| Mar2024 | ₹211 Cr | 22.46 | |
| Mar2023 | ₹173 Cr | 132.88 | |
| Mar2022 | ₹74 Cr | - | |
Compare Capital Work in Progress of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,472.0 Cr | -4.2% | -3.9% | -27.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | -4.2% |
-3.9% |
-27.7% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses